Kilitch Drugs (India) Limited (KILITCH) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.025x

Based on the latest financial reports, Kilitch Drugs (India) Limited (KILITCH) has a cash flow conversion efficiency ratio of -0.025x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-66.20 Million ≈ $-715.95K USD) by net assets (Rs2.64 Billion ≈ $28.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Kilitch Drugs (India) Limited balance sheet quality to measure how much of total assets are equity-financed.

Kilitch Drugs (India) Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Kilitch Drugs (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check KILITCH cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Kilitch Drugs (India) Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kilitch Drugs (India) Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Tecnotree Oyj
HE:TEM1V
0.035x
Technology & Telecommunication
NASDAQ:TETE
0.010x
Anfield Energy Inc.
NASDAQ:AEC
-0.070x
Altenergy Acquisition Corp
NASDAQ:AEAE
0.017x
GaeaSoft Corp
KQ:051160
0.074x
Interpark Co. Ltd
KQ:035080
0.004x
Magna Prima Bhd
KLSE:7617
0.138x
Taekyung BK Co Ltd
KO:014580
0.037x

Annual Cash Flow Conversion Efficiency for Kilitch Drugs (India) Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Kilitch Drugs (India) Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see KILITCH market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs2.00 Billion
≈ $21.68 Million
Rs175.42 Million
≈ $1.90 Million
0.088x +10608.11%
2024-03-31 Rs1.76 Billion
≈ $19.00 Million
Rs-1.46 Million
≈ $-15.82K
-0.001x -104.85%
2023-03-31 Rs1.51 Billion
≈ $16.28 Million
Rs25.86 Million
≈ $279.64K
0.017x -58.34%
2022-03-31 Rs1.40 Billion
≈ $15.17 Million
Rs57.83 Million
≈ $625.41K
0.041x -88.31%
2021-03-31 Rs1.29 Billion
≈ $14.00 Million
Rs456.59 Million
≈ $4.94 Million
0.353x +1034.35%
2020-03-31 Rs1.20 Billion
≈ $13.03 Million
Rs37.45 Million
≈ $405.02K
0.031x +1216.09%
2019-03-31 Rs1.23 Billion
≈ $13.32 Million
Rs2.91 Million
≈ $31.46K
0.002x -81.28%
2018-03-31 Rs1.13 Billion
≈ $12.19 Million
Rs14.23 Million
≈ $153.90K
0.013x +13.89%
2017-03-31 Rs1.01 Billion
≈ $10.94 Million
Rs11.21 Million
≈ $121.28K
0.011x -93.01%
2016-03-31 Rs1.09 Billion
≈ $11.75 Million
Rs172.33 Million
≈ $1.86 Million
0.159x +349.49%
2015-03-31 Rs1.20 Billion
≈ $12.96 Million
Rs-76.18 Million
≈ $-823.90K
-0.064x +75.42%
2014-03-31 Rs1.20 Billion
≈ $13.00 Million
Rs-310.84 Million
≈ $-3.36 Million
-0.259x -2155.68%
2013-03-31 Rs1.19 Billion
≈ $12.88 Million
Rs14.97 Million
≈ $161.93K
0.013x +104.95%
2012-03-31 Rs1.16 Billion
≈ $12.50 Million
Rs-293.49 Million
≈ $-3.17 Million
-0.254x -217.16%
2011-03-31 Rs858.72 Million
≈ $9.29 Million
Rs186.05 Million
≈ $2.01 Million
0.217x +3.92%
2010-03-31 Rs740.88 Million
≈ $8.01 Million
Rs154.46 Million
≈ $1.67 Million
0.208x +27.83%
2009-03-31 Rs643.97 Million
≈ $6.96 Million
Rs105.03 Million
≈ $1.14 Million
0.163x +120.74%
2008-03-31 Rs513.18 Million
≈ $5.55 Million
Rs-403.48 Million
≈ $-4.36 Million
-0.786x -189.85%
2007-03-31 Rs135.84 Million
≈ $1.47 Million
Rs118.87 Million
≈ $1.29 Million
0.875x +22.51%
2006-03-31 Rs116.74 Million
≈ $1.26 Million
Rs83.39 Million
≈ $901.79K
0.714x --

About Kilitch Drugs (India) Limited

NSE:KILITCH India Drug Manufacturers - Specialty & Generic
Market Cap
$72.16 Million
Rs6.67 Billion INR
Market Cap Rank
#20432 Global
#1137 in India
Share Price
Rs190.86
Change (1 day)
+2.29%
52-Week Range
Rs124.45 - Rs448.80
All Time High
Rs487.85
About

Kilitch Drugs (India) Limited engages in the development and operation of the pharmaceutical business in India and internationally. The company offers various parenteral, nasal, and topical products, such as liquid ampoules, vials, dry powder injectables, and metered nasal drops for gastroenterology, non-steroidal anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, ant… Read more